The national group representing generic drug and biosimilar manufacturers is looking to replicate its success challenging ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug ...

The lawsuit asks the judge to rule that an independent hearing officer preside over the company’s administrative hearing on ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

The Indian pharmaceutical industry is aiming to more than double its size to USD 120-130 billion by 2030 as it looks to ride ...

This recall for “potential foreign material contamination” comes a month after nearly 9,000 boxes were pulled for ...

Innovation, institutions, integration, and infrastructure are the four key factors that will drive this sector ...

The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.